16:39 EDT NRx Pharmaceuticals (NRXP) files $150M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NRXP:
- NRx Pharmaceuticals (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
- NRX Pharmaceuticals Submits FDA Application for NRX-100
- NRx Pharmaceuticals (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network
- NRX Pharmaceuticals: Strategic Positioning and Market Potential Drive Buy Rating
- NRx Pharmaceuticals (NASDAQ: NRXP) Files ANDA for Preservative-Free IV Ketamine